Literature DB >> 18990453

Profile of auditory information-processing deficits in schizophrenia.

Bruce I Turetsky1, Warren B Bilker, Steven J Siegel, Christian G Kohler, Raquel E Gur.   

Abstract

Schizophrenia patients exhibit abnormalities in several different auditory event-related potential (ERP) measures. It is unclear how these abnormalities relate to each other, since multiple measures are rarely acquired from the same sample. This study addressed two related questions: 1) Are specific auditory ERP measures differentially impaired in schizophrenia? 2) Do abnormalities co-aggregate within the same patients? Nine auditory ERP measures were acquired in a single testing session from 23 schizophrenia patients and 22 healthy subjects. Hierarchical oblique factor analysis revealed that these measures aggregated into four factors, with each loading primarily on a single factor. Patient deficits were observed for two independent factors: N100/mismatch negativity (MMN) and P3a/P3b. N100/MMN abnormalities were associated with symptoms of alogia and formal thought disorder. P3a/P3b abnormalities were associated with avolition, attentional disturbances and delusions. We conclude that deficits in different ERP measures of early sensory processing at the level of the auditory cortex co-occur in patients. These likely represent a single differential deficit indexing the physiological abnormality underlying impaired language and verbal processing. This is relatively independent of a higher cortical deficit that mediates cognitive stimulus evaluation and underlies deficits in motivation, attention and reality testing. Such multidimensional profiling of ERP abnormalities may help to clarify the clinical and genetic heterogeneity of schizophrenia.

Entities:  

Mesh:

Year:  2008        PMID: 18990453      PMCID: PMC2652872          DOI: 10.1016/j.psychres.2008.04.013

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  39 in total

1.  Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients.

Authors:  A I Weike; U Bauer; A O Hamm
Journal:  Biol Psychiatry       Date:  2000-01-01       Impact factor: 13.382

2.  The effects of imipramine on P50 suppression, prepulse inhibition and habituation of the startle response in humans.

Authors:  Trine-Bjoerg Hammer; Bob Oranje; Birte Y Glenthoj
Journal:  Int J Neuropsychopharmacol       Date:  2007-01-25       Impact factor: 5.176

Review 3.  P50 sensory gating ratios in schizophrenics and controls: a review and data analysis.

Authors:  Julie V Patterson; William P Hetrick; Nash N Boutros; Yi Jin; Curt Sandman; Hal Stern; Steven Potkin; William E Bunney
Journal:  Psychiatry Res       Date:  2008-01-09       Impact factor: 3.222

4.  Prepulse inhibition and P50 suppression: commonalities and dissociations.

Authors:  Bob Oranje; Mark A Geyer; Koen B E Bocker; J Leon Kenemans; Marinus N Verbaten
Journal:  Psychiatry Res       Date:  2006-07-31       Impact factor: 3.222

5.  Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function.

Authors:  Neal R Swerdlow; Gregory A Light; Kristin S Cadenhead; Joyce Sprock; Ming H Hsieh; David L Braff
Journal:  Arch Gen Psychiatry       Date:  2006-12

6.  Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications.

Authors:  G A Light; M A Geyer; B A Clementz; K S Cadenhead; D L Braff
Journal:  Am J Psychiatry       Date:  2000-05       Impact factor: 18.112

Review 7.  Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures.

Authors:  Bruce I Turetsky; Monica E Calkins; Gregory A Light; Ann Olincy; Allen D Radant; Neal R Swerdlow
Journal:  Schizophr Bull       Date:  2006-11-29       Impact factor: 9.306

8.  Increased hemodynamic response in the hippocampus, thalamus and prefrontal cortex during abnormal sensory gating in schizophrenia.

Authors:  Jason R Tregellas; Deana B Davalos; Donald C Rojas; Merilyne C Waldo; Linzi Gibson; Korey Wylie; Yiping P Du; Robert Freedman
Journal:  Schizophr Res       Date:  2007-03-02       Impact factor: 4.939

9.  Prepulse inhibition and P50 suppression are both deficient but not correlated in schizophrenia patients.

Authors:  David L Braff; Gregory A Light; Neal R Swerdlow
Journal:  Biol Psychiatry       Date:  2006-12-08       Impact factor: 13.382

10.  Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia.

Authors:  Neal R Swerdlow; Joyce Sprock; Gregory A Light; Kristin Cadenhead; Monica E Calkins; Dorcas J Dobie; Robert Freedman; Michael F Green; Tiffany A Greenwood; Raquel E Gur; Jim Mintz; Ann Olincy; Keith H Nuechterlein; Allen D Radant; Nicholas J Schork; Larry J Seidman; Larry J Siever; Jeremy M Silverman; William S Stone; Debbie W Tsuang; Ming T Tsuang; Bruce I Turetsky; David L Braff
Journal:  Schizophr Res       Date:  2007-03-08       Impact factor: 4.939

View more
  45 in total

1.  Relationships between sensory "gating out" and sensory "gating in" of auditory evoked potentials in schizophrenia: a pilot study.

Authors:  Klevest Gjini; Cynthia Arfken; Nash N Boutros
Journal:  Schizophr Res       Date:  2010-05-26       Impact factor: 4.939

2.  Delayed preattentional functioning in early psychosis patients with cannabis use.

Authors:  Nicole Pesa; Daniel F Hermens; Robert A Battisti; Manreena Kaur; Ian B Hickie; Nadia Solowij
Journal:  Psychopharmacology (Berl)       Date:  2012-03-09       Impact factor: 4.530

Review 3.  Anticipating the future: automatic prediction failures in schizophrenia.

Authors:  Judith M Ford; Daniel H Mathalon
Journal:  Int J Psychophysiol       Date:  2011-09-28       Impact factor: 2.997

4.  Timing is everything: neural response dynamics during syllable processing and its relation to higher-order cognition in schizophrenia and healthy comparison subjects.

Authors:  Corby L Dale; Anne M Findlay; R Alison Adcock; Mary Vertinski; Melissa Fisher; Alexander Genevsky; Stephanie Aldebot; Karuna Subramaniam; Tracy L Luks; Gregory V Simpson; Srikantan S Nagarajan; Sophia Vinogradov
Journal:  Int J Psychophysiol       Date:  2009-10-28       Impact factor: 2.997

Review 5.  Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia.

Authors:  Michael J Gandal; J Christopher Edgar; Kerstin Klook; Steven J Siegel
Journal:  Neuropharmacology       Date:  2011-02-22       Impact factor: 5.250

6.  Automatic sensory information processing abnormalities across the illness course of schizophrenia.

Authors:  C Jahshan; K S Cadenhead; A J Rissling; K Kirihara; D L Braff; G A Light
Journal:  Psychol Med       Date:  2011-07-11       Impact factor: 7.723

7.  A longitudinal study of event related potentials and correlations with psychosocial functioning and clinical features in first episode psychosis patients.

Authors:  Caitlin K Monaghan; Sophie Brickman; Polly Huynh; Dost Öngür; Mei-Hua Hall
Journal:  Int J Psychophysiol       Date:  2019-05-17       Impact factor: 2.997

8.  Cholinergic modulation of auditory processing, sensory gating and novelty detection in human participants.

Authors:  Inge Klinkenberg; Arjan Blokland; Wim J Riedel; Anke Sambeth
Journal:  Psychopharmacology (Berl)       Date:  2012-10-03       Impact factor: 4.530

Review 9.  Sensory processing in schizophrenia: neither simple nor intact.

Authors:  Daniel C Javitt
Journal:  Schizophr Bull       Date:  2009-10-15       Impact factor: 9.306

Review 10.  Cellular and circuit models of increased resting-state network gamma activity in schizophrenia.

Authors:  R S White; S J Siegel
Journal:  Neuroscience       Date:  2015-11-11       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.